These results suggest that the autophagic genes beclin-1 and LC3 play an important role in the progression and prognosis of hypopharyngeal squamous cell carcinoma, and could be novel therapeutic targets for future treatment of human hypopharyngeal squamous cell carcinomas. This evidence concerns the gene MAP1LC3A and hypopharynx squamous cell carcinoma.